Other
All other operating activities
Year-over-year, this metric grew by 115.5%, from -$19.35M to $2.99M. Over 4 years (FY 2021 to FY 2025), All other operating activities shows a downward trend with a 13.1% CAGR.
Analysis
StatementIncome Statement
SectionOther
CategoryEfficiency
SignalContext dependent
VolatilityModerate
First reportedQ1 2017
Last reportedQ1 2026Apr 30, 2026
How to read this metric
Large fluctuations may indicate non-recurring operational adjustments or accounting reclassifications that require further investigation.
Detailed definition
Captures miscellaneous cash inflows and outflows from operating activities that do not fit into standard categories like...
Peer comparison
Standard line item in cash flow statements across all industries; varies significantly based on company-specific accounting practices.
Metric ID:
other_other_operating_activities_cash_flow_statementHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.58M | -$16.78M | $3.68M | $7.40M | $10.44M | $2.78M | -$20.78M | -$6.28M | -$1.98M | $23.34M | -$17.47M | -$6.51M | -$11.78M | -$13.94M | -$6.76M | -$19.35M | -$18.51M | $6.40M | $0.00 | $2.99M |
| QoQ Change | — | <-999% | +121.9% | +101.2% | +41.1% | -73.4% | -848.4% | +69.8% | +68.5% | >999% | -174.8% | +62.7% | -80.9% | -18.3% | +51.5% | -186.3% | +4.4% | +134.6% | -100.0% | — |
| YoY Change | — | — | — | — | +562.5% | +116.5% | -665.6% | -184.9% | -118.9% | +740.5% | +16.0% | -3.8% | -496.1% | -159.7% | +61.3% | -197.2% | -57.1% | +145.9% | +100.0% | +115.5% |
Range-$20.78M – $23.34M
CAGR+14.5%
Avg YoY Growth-1.6%
Median YoY Growth+6.1%
All other operating activities at Other Companies
Frequently Asked Questions
- What is Alnylam Pharmaceuticals's all other operating activities?
- Alnylam Pharmaceuticals (ALNY) reported all other operating activities of $2.99M in Q1 2026.
- How has Alnylam Pharmaceuticals's all other operating activities changed year-over-year?
- Alnylam Pharmaceuticals's all other operating activities increased by 115.5% year-over-year, from -$19.35M to $2.99M.
- What is the long-term trend for Alnylam Pharmaceuticals's all other operating activities?
- Over 4 years (2021 to 2025), Alnylam Pharmaceuticals's all other operating activities has grown at a 13.1% compound annual growth rate (CAGR), from $19.24M to -$31.46M.
- What does all other operating activities mean?
- Miscellaneous cash movements related to day-to-day business operations not classified elsewhere.